close 74% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Investeringen brengen risico`s met zich mee en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 74% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

LLY

902.07

-1.52%↓

JNJ

241.06

-0.02%↓

ABBV

210.65

+1.54%↑

NVS

150.35

-0.71%↓

MRK

119.42

-0.12%↓

LLY

902.07

-1.52%↓

JNJ

241.06

-0.02%↓

ABBV

210.65

+1.54%↑

NVS

150.35

-0.71%↓

MRK

119.42

-0.12%↓

LLY

902.07

-1.52%↓

JNJ

241.06

-0.02%↓

ABBV

210.65

+1.54%↑

NVS

150.35

-0.71%↓

MRK

119.42

-0.12%↓

LLY

902.07

-1.52%↓

JNJ

241.06

-0.02%↓

ABBV

210.65

+1.54%↑

NVS

150.35

-0.71%↓

MRK

119.42

-0.12%↓

LLY

902.07

-1.52%↓

JNJ

241.06

-0.02%↓

ABBV

210.65

+1.54%↑

NVS

150.35

-0.71%↓

MRK

119.42

-0.12%↓

Home・Aandelen Lijst・CEL-SCI Corp
Search

CEL-SCI Corp

Open

SectorGezondheidszorg

3.29 -5.19

Prijsupdate 26 mrt 2026, 17:50 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

3.29

Max

3.52

Belangrijke statistieken

By Trading Economics

Inkomsten

631K

-5.5M

EPS

-0.68

EBITDA

607K

-4.4M

Dividenden

By Dow Jones

Volgende Winsten

14 mei 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-12M

29M

Vorige openingsprijs

8.48

Vorige sluitingsprijs

3.29

Nieuwssentiment

By Acuity

61%

39%

296 / 350 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

N/A / 0.2494 Steun & Weerstand

CEL-SCI Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

25 mrt 2026, 20:20 UTC

Acquisities, Fusies, Overnames

Infosys Agrees to Acquire Stratus

DJ

Lezen

25 mrt 2026, 23:58 UTC

Winsten

Guming Proposes 2025 Final Dividend of HK$0.50 >1364.HK

DJ

Lezen

25 mrt 2026, 23:58 UTC

Winsten

Guming: Seek to Further Expand Coffee Product Line, Explore New Food Categories >1364.HK

DJ

Lezen

25 mrt 2026, 23:57 UTC

Winsten

Guming: Aim to Expand Store Network in China, Evaluate Overseas Opportunities >1364.HK

DJ

Lezen

25 mrt 2026, 23:57 UTC

Winsten

Guming Store Network Rose 37% on Year to 13,554 Stores as of Dec. 31, 2025 >1364.HK

DJ

Lezen

25 mrt 2026, 23:56 UTC

Winsten

Guming 2025 Rev CNY12.91B Vs. CNY8.79B >1364.HK

DJ

Lezen

25 mrt 2026, 23:56 UTC

Winsten

Guming 2025 Net CNY3.11B Vs. Net CNY1.48B >1364.HK

DJ

Lezen

25 mrt 2026, 23:41 UTC

Marktinformatie

Nikkei May Trade Rangebound Amid Uncertainty Over U.S.-Iran Talks -- Market Talk

DJ

Lezen

25 mrt 2026, 23:41 UTC

Winsten

These Stocks Are Today's Movers: Arm, Intel, AMD, Firefly Aerospace, Robinhood, JD.com, Sarepta, and More -- Barrons.com

DJ

Lezen

25 mrt 2026, 23:34 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Gold Declines on Possible Technical Correction -- Market Talk

DJ

Lezen

25 mrt 2026, 22:08 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lezen

25 mrt 2026, 22:08 UTC

Marktinformatie

Synlait Milk's Outlook Depends on Dunsandel -- Market Talk

DJ

Lezen

25 mrt 2026, 22:07 UTC

Winsten

China Mengniu Dairy: Weak Consumer Demand Weighed on Rev >2319.HK

DJ

Lezen

25 mrt 2026, 22:07 UTC

Winsten

China Mengniu Dairy Plans Steady Increase in Dividends For Next Three Years >2319.HK

DJ

Lezen

25 mrt 2026, 22:07 UTC

Winsten

China Mengniu Dairy: 2025 Net Supported by Absence of Impairment Provisions Made Last Year >2319.HK

DJ

Lezen

25 mrt 2026, 22:07 UTC

Winsten

China Mengniu Dairy 2025 Rev CNY82.24B Vs. CNY88.67B >2319.HK

DJ

Lezen

25 mrt 2026, 22:07 UTC

Winsten

China Mengniu Dairy 2025 Net CNY1.55B Vs. Net CNY104.51M >2319.HK

DJ

Lezen

25 mrt 2026, 21:58 UTC

Marktinformatie

Amplitude Energy Oversold on Isabella-1 Well Disappointment -- Market Talk

DJ

Lezen

25 mrt 2026, 21:37 UTC

Marktinformatie

Miran: AI and Deregulation Are Positive Supply Shocks To Economy -- Market Talk

DJ

Lezen

25 mrt 2026, 21:14 UTC

Acquisities, Fusies, Overnames

St Barbara: Expects to Record Gain on Sale of Roughly A$500 Million Upon Completion

DJ

Lezen

25 mrt 2026, 21:13 UTC

Acquisities, Fusies, Overnames

St Barbara: All Conditions Satisfied, Waived on Lingbao Deal

DJ

Lezen

25 mrt 2026, 21:12 UTC

Acquisities, Fusies, Overnames

Closing M&A Deals Bring Opportunity. Janus Henderson and Other Stocks to Buy. -- Barrons.com

DJ

Lezen

25 mrt 2026, 20:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

DJ

Lezen

25 mrt 2026, 20:50 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Health Care Roundup: Market Talk

DJ

Lezen

25 mrt 2026, 20:33 UTC

Acquisities, Fusies, Overnames

KKR & Co.: Entered Agreement to Sell CoolIT Systems to Ecolab in Transaction Valued at $4.75B >KKR >KKR

DJ

Lezen

25 mrt 2026, 20:31 UTC

Winsten

The SpaceX IPO Is Coming. Cathie Wood's Ark Venture and More Funds to Get in on the Action. -- Barrons.com

DJ

Lezen

25 mrt 2026, 20:15 UTC

Acquisities, Fusies, Overnames

KKR Scores One of Its Best Bets With Sale of Data-Center Cooling Business -- WSJ

DJ

Lezen

25 mrt 2026, 20:15 UTC

Acquisities, Fusies, Overnames

CoolIT Employees Set to Receive Average Payouts of $240,000, Executives Say -- WSJ

DJ

Lezen

25 mrt 2026, 20:15 UTC

Acquisities, Fusies, Overnames

CoolIT Deal Ranks Among KKR's Top-4 Highest Earning Investments in Past 20 Years, Executives Say -- WSJ

DJ

Lezen

25 mrt 2026, 20:15 UTC

Acquisities, Fusies, Overnames

KKR Set to Make 15x Investment From $4.75B Sale of CoolIT to Ecolab, Executives Say -- WSJ

DJ

Lezen

Peer Vergelijking

Prijswijziging

CEL-SCI Corp Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Gebaseerd op 0 analisten die aandelenratings hebben gegeven aan CEL-SCI Corp - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

N/A / 0.2494Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Gemiddeld Termijn

Bullish Evidence

There is one bullish event.

Lange Termijn

Weak Bearish Evidence

There is one bearish event.

Sentiment

By Acuity

296 / 350 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

902.07

↓-1.52%

JNJ

Johnson and Johnson

241.06

↓-0.02%

ABBV

AbbVie Inc

210.65

↑ +1.54%

NVS

Novartis AG

150.35

↓-0.71%

MRK

Merck & Co Inc.

119.42

↓-0.12%
help-icon Live chat